Patent · US Active

Peptides for treating cancer

US10064911B2 · kind B2 · utility

0Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 22, 2017
Grant dateSep 4, 2018
Priority date
Expiry dateMay 22, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2009/00872
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to peptides for inhibiting angiogenesis. The present invention also relates to methods of inhibiting angiogenesis and methods of treating disorders associated with VEGF-induced vascular permeability using the peptides of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.